Walgreens Boots Alliance Inc.’s chairman and biggest shareholder, Stefano Pessina, has dealmaking in his DNA. Yet finding a ...
Private equity firm Sycamore Partners has been speaking with private credit firms about debt financing for a potential Walgreens deal, according to people familiar with the matter, despite an ...
Find out why Walgreens Boots Alliance (WBA) stock fell over 7% in extended trading and why the drugstore chain is suspending ...
Walgreens Boots (WBA) falls 6.6% as potential takeover by Sycamore Partners unlikely to happen due to DOJ lawsuit over opioid prescriptions.
A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York private-equity firm Sycamore Partners is “mostly dead.” Walgreen’s ...
Shares of Walgreens Boots Alliance dropped 10% Friday, after the pharmacy chain suspended quarterly dividends, citing the ...
Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...
CNBC’s David Faber reported on air this morning that sources say the possible deal in which Walgreens would sell itself to New York-based Sycamore Partners is “mostly dead.” One count ...
Walgreens suspends its quarterly dividend for the first time in 92 years as it faces challenges in its financial turnaround effort.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results